semaglutide and marijuana New research defines impact of cannabis on health Review of cannabis use on

For semaglutide, some adverse reactions discovered after approval include: Ileus When the intestinal tract stops moving normally

Nearly 15% of people who took a GLP-1 drug to treat obesity stopped taking the drugs due to side effects, according to a 2025 survey conducted by KFF

Contrave is already a combination drug, with the active ingredients bupropion and naltrexone, which are not individually approved for weight loss but work together to aid in chronic weight management

In the closing three months of the year, US healthcare providers wrote more than nine million prescriptions for Ozempic, Wegovy, and other GLP-1 drugs, with Novos Ozempic making up more than 65% of total prescriptions primarily off-label for weight loss purposes